ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HIK Hikma Pharmaceuticals Plc

1,953.00
18.00 (0.93%)
20 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  18.00 0.93% 1,953.00 1,951.00 1,952.00 1,959.00 1,919.00 1,932.00 801,595 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8653 22.56 4.29B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,935p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,750.00p to 2,165.00p.

Hikma Pharmaceuticals currently has 221,886,453 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.29 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 22.56.

Hikma Pharmaceuticals Share Discussion Threads

Showing 901 to 925 of 1875 messages
Chat Pages: Latest  39  38  37  36  35  34  33  32  31  30  29  28  Older
DateSubjectAuthorDiscuss
20/2/2018
07:26
Teva chap joins Hikma. I'm not seeing this as a bad thing..
r ball
19/2/2018
12:29
Thanks Mr T - I'm assuming market sentiment is upbeat? Or should I place these HIKshares firmly at the bottom of my in-tray until 45th Julember? :-/
nickg100
19/2/2018
09:20
it may be worth a buy at 9.10 given results out very soon and assume made a small profit could make a 10/20% gain over a short period.

of course if good news about products that will help and no cash burn

but a risk still but could have bottom may be at last

mrthomas
17/2/2018
19:13
In view of Hikma's 52 week high of 2346p.... ..meeting us half way on the share price with "less negative' news will, without doubt, turn this dog into a diamond! Here's to blue and bullish forth coming week with Hikma. A well tipped and fancied company at the start of 2018. Is this Hikma's chance to shine??
nickg100
17/2/2018
18:08
At least less megative. It would be a brave analyst to disagree with buffett
r ball
17/2/2018
11:04
Have we now reason & optimism to be bullish about Hikma?
nickg100
16/2/2018
20:36
Berkshire Hathaway has bought into teva. Read across to Hikma. Has the market bottom been called?
r ball
09/2/2018
12:34
Teva (NYSE) results yesterday and they were terrible....
r ball
09/2/2018
11:34
What is up with this share? Thought this was a company going places and making it happen?!
nickg100
09/2/2018
10:25
this looks very bad. its under 886p major support level..next support at 765p then 726p. take your pick.
citytrader66
07/2/2018
21:26
Q4 last yr was 4th April , this year Sharepad has Q4 as 14th March.DbD
death by donut
07/2/2018
19:00
14th March final result for 2017. I need to check, I thought this Friday they will release their Q4 2017 results. I need to check.
karateboy
06/2/2018
08:25
Karate boy,what RNS are you expecting Friday?
fhmktg
05/2/2018
18:25
Let's go through this Friday first. share price dropped from £22 to £9 following FDA decision last year. Any sign of resolution of this issue share price should recover.lets see what Friday RNS says about this.
karateboy
05/2/2018
00:04
Not unlikely imho
isstaaz
03/2/2018
19:19
Any chance of a takeover?
ianstrain
02/2/2018
21:29
Next Friday is crucial for the poor share holders like me. Let's hope Hik has some good news regarding its long standing FDA application.
karateboy
01/2/2018
10:11
Way oversold. JPM & co are targeting process and people costs, which are the bulk of healthcare costs. Pharma costs are a small %age
isstaaz
31/1/2018
09:40
JPM, Hathaway and amazon news a downwer
bantam175
23/1/2018
08:58
You can also count on Deutsche bank to be a contra indicator.....
r ball
20/1/2018
19:12
Twice HIK bounced back from 950p. Hopefully share price remains above 950p until the update in March.
karateboy
12/1/2018
09:50
Full year result for 2017 to be announced on 14 March 2018. Trading update on 9th November 2017 was very positive. There is an issue beyond company's control is the devaluation of Egyptian pound. It was devalued in November from 8.8 to 17.6. So currently 17.6 Egyptian pounds buys you one USA dollar. This is good in one hand if your earning is in USA $, but makes goods produced in Egypt expensive ....I hope the company stops the share price drift south by updating the market befor 14th of March with some good news such as progress with PROGRESS with FDA submission.
karateboy
12/1/2018
08:54
If its any consolation, I was holding AAL when they dropped to £2.20 and were
ranked as junk status. today they are sitting at £17.54.
OK its a different sector, but you never know.

richrost
11/1/2018
19:06
What are your thoughts on the outlook for this to keep? I bought back then it was 16 so was thinking if I should cut losses or wait out for better times? Is it worth to wait at all? Thanks
bobogyo
10/1/2018
08:59
No worries then. Just flapping their lips to feel the breeze.
bantam175
Chat Pages: Latest  39  38  37  36  35  34  33  32  31  30  29  28  Older

Your Recent History

Delayed Upgrade Clock